How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
17
LABU Quote, Financials, Valuation and Earnings
Last price:
$98.19
Seasonality move
:
-9.66%
Day range:
$93.23 - $98.85
52-week range:
$80.41 - $176.99
Dividend yield:
0.57%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
800.3K
Avg. volume:
1.3M
1-year change:
-20.32%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | -- | -- | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | -- | -- | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | -- | -- | -- | -- |
|
UWM
ProShares Ultra Russell2000
|
-- | -- | -- | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
$98.29 | -- | -- | -- | $0.15 | 0.57% | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
$36.36 | -- | -- | -- | $0.25 | 1.73% | -- |
|
ROM
ProShares Ultra Technology
|
$74.58 | -- | -- | -- | $0.03 | 0.2% | -- |
|
UDOW
ProShares UltraPro Dow30
|
$99.59 | -- | -- | -- | $0.15 | 0.9% | -- |
|
UWM
ProShares Ultra Russell2000
|
$42.88 | -- | -- | -- | $0.18 | 1.13% | -- |
|
UYG
ProShares Ultra Financials
|
$87.99 | -- | -- | -- | $0.20 | 0.49% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | 5.522 | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | -1.223 | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | 2.473 | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | 2.749 | -- | -- |
|
UWM
ProShares Ultra Russell2000
|
-- | 3.000 | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | 1.709 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | -- | -- | -- | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | -- | -- | -- | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | -- | -- | -- | -- | -- |
|
UWM
ProShares Ultra Russell2000
|
-- | -- | -- | -- | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | -- | -- | -- | -- | -- |
Direxion Daily S&P Biotech Bull 3X Shares vs. Competitors
-
Which has Higher Returns LABU or NUGT?
Direxion Daily Gold Miners Index Bull 2X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily Gold Miners Index Bull 2X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- NUGTDirexion Daily Gold Miners Index Bull 2X Shares-- -- -- -
What do Analysts Say About LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Gold Miners Index Bull 2X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily Gold Miners Index Bull 2X Shares, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily Gold Miners Index Bull 2X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 NUGTDirexion Daily Gold Miners Index Bull 2X Shares0 0 0 -
Is LABU or NUGT More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison Direxion Daily Gold Miners Index Bull 2X Shares has a beta of 2.359, suggesting its more volatile than the S&P 500 by 135.859%.
-
Which is a Better Dividend Stock LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.57%. Direxion Daily Gold Miners Index Bull 2X Shares offers a yield of 1.73% to investors and pays a quarterly dividend of $0.25 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily Gold Miners Index Bull 2X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Gold Miners Index Bull 2X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily Gold Miners Index Bull 2X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily Gold Miners Index Bull 2X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily Gold Miners Index Bull 2X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- NUGTDirexion Daily Gold Miners Index Bull 2X Shares-- -- -- --
-
Which has Higher Returns LABU or ROM?
ProShares Ultra Technology has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- ROMProShares Ultra Technology-- -- -- -
What do Analysts Say About LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Technology, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Technology.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 ROMProShares Ultra Technology0 0 0 -
Is LABU or ROM More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison ProShares Ultra Technology has a beta of 2.327, suggesting its more volatile than the S&P 500 by 132.701%.
-
Which is a Better Dividend Stock LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.57%. ProShares Ultra Technology offers a yield of 0.2% to investors and pays a quarterly dividend of $0.03 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Technology quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Technology's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- ROMProShares Ultra Technology-- -- -- --
-
Which has Higher Returns LABU or UDOW?
ProShares UltraPro Dow30 has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares UltraPro Dow30's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UDOWProShares UltraPro Dow30-- -- -- -
What do Analysts Say About LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares UltraPro Dow30 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares UltraPro Dow30, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares UltraPro Dow30.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UDOWProShares UltraPro Dow300 0 0 -
Is LABU or UDOW More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison ProShares UltraPro Dow30 has a beta of 2.907, suggesting its more volatile than the S&P 500 by 190.706%.
-
Which is a Better Dividend Stock LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.57%. ProShares UltraPro Dow30 offers a yield of 0.9% to investors and pays a quarterly dividend of $0.15 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares UltraPro Dow30 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares UltraPro Dow30 quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares UltraPro Dow30's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares UltraPro Dow30's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares UltraPro Dow30. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UDOWProShares UltraPro Dow30-- -- -- --
-
Which has Higher Returns LABU or UWM?
ProShares Ultra Russell2000 has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Russell2000's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UWMProShares Ultra Russell2000-- -- -- -
What do Analysts Say About LABU or UWM?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Russell2000 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Russell2000, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Russell2000.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UWMProShares Ultra Russell20000 0 0 -
Is LABU or UWM More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison ProShares Ultra Russell2000 has a beta of 2.307, suggesting its more volatile than the S&P 500 by 130.719%.
-
Which is a Better Dividend Stock LABU or UWM?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.57%. ProShares Ultra Russell2000 offers a yield of 1.13% to investors and pays a quarterly dividend of $0.18 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Russell2000 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UWM?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Russell2000 quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Russell2000's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Russell2000's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Russell2000. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UWMProShares Ultra Russell2000-- -- -- --
-
Which has Higher Returns LABU or UYG?
ProShares Ultra Financials has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Financials's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UYGProShares Ultra Financials-- -- -- -
What do Analysts Say About LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Financials has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Financials, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Financials.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UYGProShares Ultra Financials0 0 0 -
Is LABU or UYG More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, which suggesting that the stock is 186.014% more volatile than S&P 500. In comparison ProShares Ultra Financials has a beta of 2.124, suggesting its more volatile than the S&P 500 by 112.388%.
-
Which is a Better Dividend Stock LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.57%. ProShares Ultra Financials offers a yield of 0.49% to investors and pays a quarterly dividend of $0.20 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Financials pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Financials quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Financials's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Financials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Financials. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UYGProShares Ultra Financials-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
